Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06399861 · ClinicalTrials.gov registry record · NA
Humidity in Incubators for Tiny Infants
A NA study of Extremely Premature Infant, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 6
- Study locations
NCT06399861: Recruiting NA study of Extremely Premature Infant, sponsored by The University of Texas Health Science Center, Houston.
NCT06399861 is a NA study of Extremely Premature Infant that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06399861, a NA study of Extremely Premature Infant, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 6
- Study locations
Study Summary
The objective of the study is to assess 2 different initial incubator humidification protocols for infants \<25 weeks' gestation admitted to the neonatal intensive care unit (NICU). The hypothesis is that a higher starting humidity decreases dehydration and results in no difference in survival or morbidity. Higher (90%) and lower (70%) starting humidity will be compared.
Primary Outcome
A single composite safety score will be reported (mortality and 6 morbidities will be assessed to determine this score). The composite score ranges from 0 to 7, with a higher score indicating a better outcome, as listed below: * 0 = Infant does not survive * 1 = Infant survives, has all 6 assessed morbidities * 2 = Infant survives, has 5 assessed morbidities * 3 = Infant survives, has 4 assessed morbidities * 4 = Infant survives, has 3 assessed morbidities * 5 = Infant survives, has 2 assessed
Conditions Studied
Interventions
- DEVICE Incubator ambient relative humidity (RH) of 70%
- DEVICE Incubator ambient relative humidity (RH) of 90%
Study Locations (6)
Texas
- Children's Memorial Hermann Hospital - Houston
- The Woman's Hospital of Texas - Houston
- St. Luke's Baptist Hospital - San Antonio
- North Central Baptist Hospital - San Antonio
Ohio
- Nationwide Children's Hospital - Grant Medical Center - Columbus
- Nationwide Children's Hospital - Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-06-25 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT06399861 shows while recruiting
NCT06399861 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Extremely Premature Infant appearing as the primary indexed condition, and to 2 interventions - of which Incubator ambient relative humidity (RH) of 70% is the first listed.
NCT06399861 lists 6 locations in 2 states (Texas, Ohio).
Frequently Asked Questions
What is clinical trial NCT06399861 about?
NCT06399861 is a clinical study titled "Humidity in Incubators for Tiny Infants". The objective of the study is to assess 2 different initial incubator humidification protocols for infants \<25 weeks' gestation admitted to the neonatal intensive care unit (NICU). The hypothesis is that a higher starting humidity decreases dehydration and results in no difference in survival or mo...
What is the current status of trial NCT06399861?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-06-25. Estimated completion is 2027-07-01.
What conditions does trial NCT06399861 study?
This clinical trial studies the following conditions: Extremely Premature Infant.
What interventions are being tested in trial NCT06399861?
The interventions under investigation include: Incubator ambient relative humidity (RH) of 70% (DEVICE), Incubator ambient relative humidity (RH) of 90% (DEVICE).
Who is sponsoring clinical trial NCT06399861?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06399861 being conducted?
This trial has 6 study locations across Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06399861's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI